Inovio Pharmaceuticals Inc. plans to initiate Phase 2/3 study trials of INO-4800, its experimental vaccine candidate against the novel coronavirus, in September and …
DryShips Inc. (NASDAQ:DRYS) shares fell hard this morning after management announced that a reverse stock split is in the cards.
On Wednesday, Inovio Pharmaceuticals Inc (NASDAQ:INO) announced that its HIV vaccine, PENNVAX-GP, had produced an antibody (humoral) immune response as well as a T cell …
Inovio Pharmaceuticals Inc (NASDAQ:INO) rose over 20% in Wednesday’s trading session, after the drug maker said its HIV vaccine Pennvax-GP achieved some of …
It’s a very rewarding trading day for investors in Inovio Pharmaceuticals Inc (NASDAQ:INO) with shares up over 35%, making the stock Wall Street’s …
Maxim analyst Jason McCarthy reiterated a Hold rating on shares of Inovio Pharmaceuticals Inc (NASDAQ:INO), after the vaccine maker presented positive clinical data for DNA-based …
Inovio Pharmaceuticals Inc (NASDAQ:INO) presented positive clinical data on Inovio’s DNA-based vaccines against MERS (Middle East Respiratory Syndrome) (GLS-5300) and Zika (GLS-5700) at …
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced that it has entered into a collaboration and license agreement providing ApolloBio Corporation (NEEQ:430187) with the exclusive right …
Inovio Pharmaceuticals Inc (NASDAQ:INO) announced its DNA-based Zika vaccine (GLS-5700) generated robust antigen-specific antibody responses in a first-in-man, multi-center phase I trial. In …
Inovio Pharmaceuticals Inc (NASDAQ:INO) released third-quarter financial earnings and a clinical progress update on the firm’s pipeline on Wednesday, November 9th. H.